Despite advances in contemporary hip and knee arthroplasty, blood loss continues to be an issue. Though blood transfusion has long been used to treat post-operative anemia, the associated risks are well established. The objective of this article is to present two practical and effective approaches to minimising blood loss and transfusion rates in hip and knee arthroplasty: the use of antifibrinolytic medications such as tranexamic acid and the adoption of more conservative transfusion indications.





Polls results
1

On a scale of 1 to 10, rate how much this article will change your clinical practice?

NO change
BIG change
100% Article relates to my practice (7/7)
0% Article does not relate to my practice (0/7)
0% Undecided (0/7)
2

Will this article lead to more cost-effective healthcare?

85% Yes (6/7)
14% No (1/7)
0% Undecided (0/7)
3

Was this article biased? (commercial or personal)

0% Yes (0/7)
100% No (7/7)
0% Undecided (0/7)
4

What level of evidence do you think this article is?

0% Level 1 (0/7)
28% Level 2 (2/7)
0% Level 3 (0/7)
42% Level 4 (3/7)
28% Level 5 (2/7)